glp-1 and pregnancy Discontinuing Receptor Agonist Use Before Tied to Risk for Adverse Outcomes MedNews GLP-1 drugs and pregnancy: Who

The first encouraging human signal came from Athauda and colleagues in 2017

doi: 10.3390/ijms22157765

Alternative Names: Tesamorelin (GHRH Analog), CJC-1295 (Modified GRF 1-29), Ipamorelin (Synthetic Pentapeptide) Tesamorelin & CJC-1295 (Mod GRF 1-29) & Ipamorelin Studies and Research Data Potential Pituitary Signaling Pathways Research on Tesamorelin and CJC-1295 suggests that they may bind to GHRH receptors, potentially initiating intracellular signaling cascades involving cyclic adenosine monophosphate (cAMP) and protein kinase pathways

Murphy RM, Watt MJ, Febbraio MA

and engineered with favorable pharmacokinetics for in vivo research